ANDA 83745, held by Sandoz. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 83745 (Imipramine Hydrochloride), held by Sandoz, was first approved by FDA on Apr 20, 1976, with 36 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 20, 1976 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride25MG · tablet;oral | Imipramine Hydrochloride | Rx |
| Jun 24, 2025 | Supplement 130Labeling · Standard review | Approved | None posted |
| May 24, 2023 | Supplement 123Labeling · Standard review | Approved | None posted |
| Feb 2, 2016 | Supplement 122Labeling · Standard review | Approved | None posted |
| Jul 17, 2014 | Supplement 121Labeling · Standard review | Approved | None posted |
| Mar 10, 2008 | Supplement 114Labeling | Approved | None posted |
| Jun 25, 2007 | Supplement 113Labeling | Approved | None posted |
| Feb 9, 2007 | Supplement 100Labeling | Approved | None posted |
| Jun 15, 2005 | Supplement 112Labeling | Approved | None posted |
| Apr 19, 2002 | Supplement 109Manufacturing | Approved | None posted |
| Oct 16, 2001 | Supplement 107Manufacturing | Approved | None posted |
| May 9, 2001 | Supplement 108Manufacturing | Approved | None posted |
| Oct 31, 2000 | Supplement 106Manufacturing | Approved | None posted |
| Jun 1, 1999 | Supplement 102Labeling | Approved | None posted |
| Jun 1, 1999 | Supplement 101Manufacturing | Approved | None posted |
| May 11, 1999 | Supplement 105Labeling | Approved | None posted |
| May 5, 1999 | Supplement 104Manufacturing | Approved | None posted |
| Apr 6, 1995 | Supplement 95Manufacturing | Approved | None posted |
| Mar 21, 1995 | Supplement 96Labeling | Approved | None posted |
| Mar 11, 1994 | Supplement 94Labeling | Approved | None posted |
| Jun 13, 1991 | Supplement 92Manufacturing | Approved | None posted |
| Jun 13, 1991 | Supplement 91Manufacturing | Approved | None posted |
| May 15, 1989 | Supplement 93Bioequivalence | Approved | None posted |
| Feb 22, 1988 | Supplement 90Manufacturing | Approved | None posted |
| Feb 22, 1988 | Supplement 89Manufacturing | Approved | None posted |
| Feb 22, 1988 | Supplement 87Manufacturing | Approved | None posted |
| Feb 22, 1988 | Supplement 86Manufacturing | Approved | None posted |
| Feb 22, 1988 | Supplement 85Manufacturing | Approved | None posted |
| May 29, 1986 | Supplement 82Manufacturing | Approved | None posted |
| Mar 11, 1986 | Supplement 79Manufacturing | Approved | None posted |
| Mar 11, 1986 | Supplement 78Manufacturing | Approved | None posted |
| Mar 11, 1986 | Supplement 77Manufacturing | Approved | None posted |
| Dec 27, 1985 | Supplement 80Manufacturing | Approved | None posted |
| Oct 21, 1983 | Supplement 72Manufacturing | Approved | None posted |
| Jul 25, 1983 | Supplement 70Manufacturing | Approved | None posted |
| Dec 10, 1982 | Supplement 67Manufacturing | Approved | None posted |
| Apr 7, 1982 | Supplement 65Manufacturing | Approved | None posted |
| Apr 20, 1976 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters